Clinical trial reportThe Lancet. Respiratory medicinePublished
Long-term safety and efficacy of twice-yearly depemokimab in type 2 asthma with an eosinophilic phenotype: 2-year integrated analysis of the phase 3a SWIFT-1 and SWIFT-2 studies and AGILE open-label extension
Regional connection
Verified An author affiliation on the Europe PMC record names GSK. Affiliation source
- Institution
- GSK
- County
- Montgomery County
Publication record
- Type
- Clinical trial report
- Venue
- The Lancet. Respiratory medicine
- Published
- Topic
- Clinical care
- PubMed ID
- 42956801
- Added to directory
- Source checked